FDA Approves Oral Combination of Decitabine and Cedazuridine for Myelodysplastic Syndromes
Cedazuridine was investigated in ASTX727-01-B and ASTX727-02 trials
Oncology News
ESMO oncology news aims to keep you up to date with the developments that affect you and your daily practice.
Make sure you check these pages frequently, or sign up to our newsletter! To sign up for ESMO newsletters, create a myESMO account here and select the newsletters you’d like to receive.
1549 results
Pyrotinib in HER2-mutated Advanced NSCLC Previously Treated with Chemotherapy
Promising antitumour activity and acceptable safety profile in patients with HER2-mutated advanced non-small cell lung cancer who had received at least one prior platinum-based chemotherapy
Oncogenic Drivers Associated with Late Recurrence in Postmenopausal Women with ER-positive/HER2-negative Early Breast Cancer
Results from the BIG 1-98 study
T-DM1 is Active and Well Tolerated in Patients with HER2-positive Metastatic Breast Cancer and Brain Metastases
Results from the KAMILLA exploratory analysis
FDA Approves Pembrolizumab for First-Line Treatment of MSI-H/dMMR Colorectal Cancer
Approval is based on findings from the KEYNOTE‑177 study
FDA Approves Avelumab for Urothelial Carcinoma Maintenance Treatment
Efficacy was investigated in the JAVELIN Bladder 100 trial
EMA Recommends Refusal of the Marketing Authorisation for Pexidartinib
It was intended for the treatment of tenosynovial giant cell tumour
FDA Approves Combination of Pertuzumab, Trastuzumab, and Hyaluronidase-zzxf for HER2-positive Breast Cancer
Efficacy was investigated in FeDeriCa trial
Outcomes From Second-Line Chemotherapy in Patients with Cholangiocarcinoma and FGFR2 Fusions
Findings from a retrospective study presented at ESMO World GI 2020 Virtual
Maintenance Olaparib in Elderly Patients With a Germline BRCA Mutation and Metastatic Pancreatic Cancer
Results from an additional analyses of phase III POLO trial by age group presented at ESMO World GI 2020 Virtual
Nivolumab vs Sorafenib in First-Line Treatment of Advanced Hepatocellular Carcinoma
Results of the CheckMate 459 study long-term survival outcomes presented at ESMO World GI 2020 Virtual
ESMO Releases New Patient Guide in Hepatocellular Carcinoma
A comprehensive new edition presents the latest information in early-, intermediate- and advanced-stage hepatocellular carcinoma